1. Home
  2. MEC vs ALT Comparison

MEC vs ALT Comparison

Compare MEC & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mayville Engineering Company Inc.

MEC

Mayville Engineering Company Inc.

HOLD

Current Price

$34.78

Market Cap

482.6M

Sector

Industrials

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.66

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEC
ALT
Founded
1945
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.6M
421.5M
IPO Year
2019
2005

Fundamental Metrics

Financial Performance
Metric
MEC
ALT
Price
$34.78
$2.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$24.33
$17.67
AVG Volume (30 Days)
636.5K
2.6M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.37
EPS
N/A
N/A
Revenue
N/A
$41,000.00
Revenue This Year
$10.65
N/A
Revenue Next Year
$8.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
105.00
52 Week Low
$12.10
$2.56
52 Week High
$35.05
$7.73

Technical Indicators

Market Signals
Indicator
MEC
ALT
Relative Strength Index (RSI) 80.32 36.19
Support Level $17.20 $2.56
Resistance Level N/A $3.20
Average True Range (ATR) 2.22 0.13
MACD 0.66 -0.02
Stochastic Oscillator 96.06 6.86

Price Performance

Historical Comparison
MEC
ALT

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, powersports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly, and logistic services.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: